Gemcitabine in pancreatic carcinoma: proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Hoboken, NJ
Wiley
2002
|
Schriftenreihe: | Cancer
95,4, Suppl. |
Schlagworte: | |
Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
Beschreibung: | V S., S. 907 - 945 Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV014773956 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 021004s2002 ad|| |||| 10||| eng d | ||
035 | |a (OCoLC)633256585 | ||
035 | |a (DE-599)BVBBV014773956 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
245 | 1 | 0 | |a Gemcitabine in pancreatic carcinoma |b proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
264 | 1 | |a Hoboken, NJ |b Wiley |c 2002 | |
300 | |a V S., S. 907 - 945 |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Cancer |v 95,4, Suppl. | |
500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
650 | 0 | 7 | |a Radioimmunologie |0 (DE-588)4176827-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2000 |z Princeton NJ |2 gnd-content | |
689 | 0 | 0 | |a Radioimmunologie |0 (DE-588)4176827-9 |D s |
689 | 0 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | |5 DE-604 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-010003352 |
Datensatz im Suchindex
_version_ | 1804129557512454144 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV014773956 |
ctrlnum | (OCoLC)633256585 (DE-599)BVBBV014773956 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01319nam a2200325 cb4500</leader><controlfield tag="001">BV014773956</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">021004s2002 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)633256585</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014773956</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gemcitabine in pancreatic carcinoma</subfield><subfield code="b">proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">V S., S. 907 - 945</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cancer</subfield><subfield code="v">95,4, Suppl.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Radioimmunologie</subfield><subfield code="0">(DE-588)4176827-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2000</subfield><subfield code="z">Princeton NJ</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Radioimmunologie</subfield><subfield code="0">(DE-588)4176827-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010003352</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 2000 Princeton NJ gnd-content |
genre_facet | Konferenzschrift 2000 Princeton NJ |
id | DE-604.BV014773956 |
illustrated | Illustrated |
indexdate | 2024-07-09T19:07:02Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010003352 |
oclc_num | 633256585 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | V S., S. 907 - 945 Ill., graph. Darst. |
publishDate | 2002 |
publishDateSearch | 2002 |
publishDateSort | 2002 |
publisher | Wiley |
record_format | marc |
series2 | Cancer |
spelling | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 Hoboken, NJ Wiley 2002 V S., S. 907 - 945 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer 95,4, Suppl. Einzelaufnahme eines Zeitschr.-Suppl. Radioimmunologie (DE-588)4176827-9 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2000 Princeton NJ gnd-content Radioimmunologie (DE-588)4176827-9 s Krebs Medizin (DE-588)4073781-0 s DE-604 |
spellingShingle | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 Radioimmunologie (DE-588)4176827-9 gnd Krebs Medizin (DE-588)4073781-0 gnd |
subject_GND | (DE-588)4176827-9 (DE-588)4073781-0 (DE-588)1071861417 |
title | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
title_auth | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
title_exact_search | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
title_full | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
title_fullStr | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
title_full_unstemmed | Gemcitabine in pancreatic carcinoma proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
title_short | Gemcitabine in pancreatic carcinoma |
title_sort | gemcitabine in pancreatic carcinoma proceedings of the virginia mason cancer center interchange meeting virginia mason cancer center seattle washington august 23 2001 this supplement is based on selected proceedings from a symposium held in conjunction with pancreas cancer 2001 in seattle wa 2001 |
title_sub | proceedings of the Virginia Mason Cancer Center interchange meeting, Virginia Mason Cancer Center, Seattle, Washington, August 23, 2001 ; this supplement is based on selected proceedings from a symposium held in conjunction with Pancreas Cancer 2001 in Seattle, WA, 2001 |
topic | Radioimmunologie (DE-588)4176827-9 gnd Krebs Medizin (DE-588)4073781-0 gnd |
topic_facet | Radioimmunologie Krebs Medizin Konferenzschrift 2000 Princeton NJ |